8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jan 10, 2012)

Filed January 10, 2012For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on January 10, 2012, primarily to disclose information regarding upcoming investor communications. During meetings with securities analysts and investors on January 10, 2012, company officers were expected to reaffirm the full-year 2011 earnings per share (EPS) guidance. The reaffirmed guidance was set in the range of $7.18 to $7.28 per share, which included net investment gains of $0.28 per share. This reaffirmation indicated that no further significant investment gains or losses were anticipated beyond those already recorded through the third quarter of 2011. The company also indicated its intention to provide detailed 2012 guidance during its fourth-quarter earnings call scheduled for January 25, 2012. This 8-K filing serves as a disclosure under Regulation FD, ensuring that material non-public information is disseminated broadly.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) reaffirmed its full-year 2011 EPS guidance of $7.18 to $7.28 per share.
  • 2The reaffirmed guidance includes $0.28 per share in net investment gains.
  • 3No additional investment gains or losses beyond those in the first three quarters of 2011 were factored into the reaffirmed guidance.
  • 4Detailed 2012 guidance is expected to be provided during the fourth-quarter earnings call on January 25, 2012.
  • 5The filing is made under Regulation FD to disclose information to analysts and investors.
  • 6The report includes a standard Safe Harbor statement related to forward-looking statements, outlining potential risks and uncertainties.

Frequently Asked Questions

The primary purpose of this 8-K filing is to disclose WellPoint, Inc.'s (now Elevance Health) reaffirmation of its full-year 2011 earnings per share guidance to securities analysts and investors during meetings held on January 10, 2012. It also announces the upcoming date for providing 2012 guidance.

WellPoint reaffirmed its earnings per share guidance for the full year 2011 to be in the range of $7.18 to $7.28 per share.

WellPoint plans to provide detailed guidance for 2012 during its fourth-quarter earnings call, which was scheduled for January 25, 2012.

The Safe Harbor statement outlines numerous risks and uncertainties that could cause actual results to differ from forward-looking statements. These include regulatory changes (like the Affordable Care Act), trends in healthcare costs and utilization, premium rate approvals, provider contracting, competition, enrollment changes, risks related to Medicare and Medicaid programs, financial strength ratings, litigation, information system failures, and general economic conditions.